Becton, Dickinson and Co. (BDX)
NYSE: BDX · Surgical & Medical Instruments & Apparatus · Franklin Lakes, NJ · filing with the SEC since 1994
Grade5.5
◀ Past 6.7● Present 5.8▶ Future 3.8
Who owns Becton, Dickinson and Co.
As filed with the SECHolders of 5% or more
4
Vanguard Capital Management holds 7.51% of Common Stock, as its SCHEDULE 13G filed Apr 29, 2026 says.
Directors and officers
28
report now, of 64 people on the record since 2006. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.
Holders of 5% or moreshare of the class, as filed
Vanguard Capital Management
SCHEDULE 13G · filed Apr 29, 2026 · Common Stock
State Street Corporation
SCHEDULE 13G · filed Aug 7, 2026 · COMMON STOCK
Vanguard Portfolio Management
SCHEDULE 13G · filed Apr 29, 2026 · Common Stock
First Eagle Investment Management, LLC
SCHEDULE 13G · filed Aug 6, 2026 · Common
T. Rowe Price Investment Management, Inc.
SCHEDULE 13G/A · filed May 15, 2026 · COMMON STOCK · reported falling below 5%, from 5.6% in Aug 14, 2025
The Vanguard Group
SCHEDULE 13G/A · filed Mar 26, 2026 · Common Stock · reported falling below 5%, from 12.8% in Jan 30, 2026
What BDX reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Advanced Patient Monitoring
A company bought · acquisition · Aug 2024 · owns, named in the 10-K filed Nov 25, 2025
345 subsidiaries in 60 countries, from the list filed with the 10-K filed Nov 25, 2025.
Insider tradesForm 4
22sales
0purchases
20sales on a scheduled plan
5people selling
$3.4Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Nov 10, 2025 to Nov 10, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 10, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window5 of 64 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Polen Thomas E Jr | Chairman, CEO and President | 3 | $1.8M | 3 | 0 | $0 |
| Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | 5 | $800,000 | 5 | 0 | $0 |
| Goette Roland | EVP and President, EMEA | 1 | $400,000 | 0 | 0 | $0 |
| Feld Michael | EVP, Chief Revenue Officer | 12 | $200,000 | 12 | 0 | $0 |
| Scott Bertram L | director | 1 | $200,000 | 0 | 0 | $0 |